Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ventricular remodeling does not accompany the development of heart failure in diabetic patients after myocardial infarction.
Solomon SD, St John Sutton M, Lamas GA, Plappert T, Rouleau JL, Skali H, Moyé L, Braunwald E, Pfeffer MA; Survival And Ventricular Enlargement (SAVE) Investigators. Solomon SD, et al. Among authors: moye l. Circulation. 2002 Sep 3;106(10):1251-5. doi: 10.1161/01.cir.0000032313.82552.e3. Circulation. 2002. PMID: 12208801 Clinical Trial.
Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD. Tokmakova MP, et al. Among authors: moye la. Circulation. 2004 Dec 14;110(24):3667-73. doi: 10.1161/01.CIR.0000149806.01354.BF. Epub 2004 Nov 29. Circulation. 2004. PMID: 15569840 Clinical Trial.
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial.
St John Sutton M, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, Rouleau J, Parker JO, Arnold MO, Sussex B, Braunwald E. St John Sutton M, et al. Among authors: moye l. Circulation. 1997 Nov 18;96(10):3294-9. doi: 10.1161/01.cir.96.10.3294. Circulation. 1997. PMID: 9396419 Clinical Trial.
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.
St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moyé LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S, et al. St John Sutton M, et al. Among authors: moye la. Circulation. 1994 Jan;89(1):68-75. doi: 10.1161/01.cir.89.1.68. Circulation. 1994. PMID: 8281697 Clinical Trial.
Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement.
Mitchell GF, Moyé LA, Braunwald E, Rouleau JL, Bernstein V, Geltman EM, Flaker GC, Pfeffer MA. Mitchell GF, et al. Among authors: moye la. Circulation. 1997 Dec 16;96(12):4254-60. doi: 10.1161/01.cir.96.12.4254. Circulation. 1997. PMID: 9416890 Clinical Trial.
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.
Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, Davis BR, Cole TG, Pfeffer MA, Braunwald E. Goldberg RB, et al. Among authors: moye la. Circulation. 1998 Dec 8;98(23):2513-9. doi: 10.1161/01.cir.98.23.2513. Circulation. 1998. PMID: 9843456 Clinical Trial.
232 results